Ann: Trading Halt, page-85

Personally, I think that would have been a disastrous message to the market. They raise capital in the last CR for building inventory to support a growing pipeline.

If they took money out of that initial strategy and refocused it to support R&D, that would advise to the market that pipeline has slowed down, thereby as have sales.

So now, it seems there's money being used on two fronts here:

1: To build inventory to support a growing pipeline
2: Current CR to support R&D

Both are separate to each other with different business goals.

Either way, its cooked for people who bought over the last few weeks as we know how CR's typically go in the short term.